v3.26.3
OPERATING SEGMENTS (Tables)
12 Months Ended
Jun. 30, 2026
OPERATING SEGMENTS  
Schedule of segment revenue and segment net income from operations

 

 

Pharmaceutical Products Distribution

 

 

Real Estate Development

 

 

Total

 

Revenue

 

$437,857

 

 

$90,000

 

 

$527,857

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues - rent

 

 

-

 

 

 

31,025

 

 

 

31,025

 

General and administrative [1]

 

 

1,627,840

 

 

 

32,500

 

 

 

1,660,340

 

Depreciation and amortization

 

 

24,497

 

 

 

9,524

 

 

 

34,021

 

Impairment expense

 

 

-

 

 

 

38,966

 

 

 

38,966

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment net income (loss) from operations

 

$(1,214,480 )

 

$(22,015 )

 

$(1,236,495 )
Schedule of reconciliation of segment operating income to net income before taxes

 

 

June 30,

2026

 

Segment loss from operations

 

$

(1,236,495

)

 

 

 

 

 

Reconciling items

 

 

 

 

Other income

 

 

10,770

 

Interest expense

 

 

(52,329 )

Loss on exchange of Series C & D preferred shares

 

 

(241,918 )

 

 

 

 

 

Net income (loss) from continued operations before income taxes

 

$

(1,519,972

)